Shibasaki Masakatsu, Kanai Motomu, Matsunaga Shigeki, Kumagai Naoya
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Hongo 7-3-1, Tokyo 113-0033, Japan.
Acc Chem Res. 2009 Aug 18;42(8):1117-27. doi: 10.1021/ar9000108.
The concept of bifunctional catalysis, wherein both partners of a bimolecular reaction are simultaneously activated, is very powerful for designing efficient asymmetric catalysts. Catalytic asymmetric processes are indispensable for producing enantiomerically enriched compounds in modern organic synthesis, providing more economical and environmentally benign results than methods requiring stoichiometric amounts of chiral reagents. Extensive efforts in this field have produced many asymmetric catalysts, and now a number of reactions can be rendered asymmetric. We have focused on the development of asymmetric catalysts that exhibit high activity, selectivity, and broad substrate generality under mild reaction conditions. Asymmetric catalysts based on the concept of bifunctional catalysis have emerged as a particularly effective class, enabling simultaneous activation of multiple reaction components. Compared with conventional catalysts, bifunctional catalysts generally exhibit enhanced catalytic activity and higher levels of stereodifferentiation under milder reaction conditions, attracting much attention as next-generation catalysts for prospective practical applications. In this Account, we describe recent advances in enantioselective catalysis with bifunctional catalysts. Since our identification of heterobimetallic rare earth-alkali metal-BINOL (REMB) complexes, we have developed various types of bifunctional multimetallic catalysts. The REMB catalytic system is effective for catalytic asymmetric Corey-Chaykovsky epoxidation and cyclopropanation. A dinucleating Schiff base has emerged as a suitable multidentate ligand for bimetallic catalysts, promoting catalytic syn-selective nitro-Mannich, anti-selective nitroaldol, and Mannich-type reactions. The sugar-based ligand GluCAPO provides a suitable platform for polymetallic catalysts; structural elucidation revealed that their higher order polymetallic structures are a determining factor for their function in the catalytic asymmetric Strecker reaction. Rational design identified a related ligand, FujiCAPO, which exhibits superior performance in catalytic asymmetric conjugate addition of cyanide to enones and a catalytic asymmetric Diels-Alder-type reaction. The combination of an amide-based ligand with a rare earth metal constitutes a unique catalytic system: the ligand-metal association is in equilibrium because of structural flexibility. These catalytic systems are effective for asymmetric amination of highly coordinative substrate as well as for Mannich-type reaction of alpha-cyanoketones, in which hydrogen bonding cooperatively contributes to substrate activation and stereodifferentiation. Most of the reactions described here generate stereogenic tetrasubstituted carbons or quaternary carbons, noteworthy accomplishments even with modern synthetic methods. Several reactions have been incorporated into the asymmetric synthesis of therapeutics (or their candidate molecules) such as Tamiflu, AS-3201 (ranirestat), GRL-06579A, and ritodrine, illustrating the usefulness of bifunctional asymmetric catalysis.
双功能催化的概念,即双分子反应的两个反应物同时被活化,对于设计高效的不对称催化剂非常有用。催化不对称过程在现代有机合成中对于制备对映体富集的化合物是不可或缺的,与需要化学计量手性试剂的方法相比,能提供更经济且环境友好的结果。该领域的大量努力已产生了许多不对称催化剂,现在许多反应都能实现不对称化。我们专注于开发在温和反应条件下具有高活性、选择性和广泛底物适用性的不对称催化剂。基于双功能催化概念的不对称催化剂已成为一类特别有效的催化剂,能够同时活化多个反应组分。与传统催化剂相比,双功能催化剂通常在更温和的反应条件下表现出更高的催化活性和立体分化水平,作为下一代有望实际应用的催化剂备受关注。在本综述中,我们描述了双功能催化剂在对映选择性催化方面的最新进展。自从我们鉴定出异双金属稀土 - 碱金属 - 联萘酚(REMB)配合物以来,我们已开发出各种类型的双功能多金属催化剂。REMB催化体系对于催化不对称的科里 - 柴科夫斯基环氧化反应和环丙烷化反应是有效的。一种双核席夫碱已成为双金属催化剂合适的多齿配体,可促进催化顺式选择性硝基 - 曼尼希反应、反式选择性硝基羟醛反应和曼尼希型反应。基于糖的配体GluCAPO为多金属催化剂提供了合适的平台;结构解析表明其高阶多金属结构是其在催化不对称斯特雷克反应中发挥作用的决定因素。合理设计确定了一种相关配体FujiCAPO,它在氰化物对烯酮的催化不对称共轭加成反应和催化不对称狄尔斯 - 阿尔德型反应中表现出优异性能。基于酰胺的配体与稀土金属的组合构成了一个独特的催化体系:由于结构灵活性,配体 - 金属缔合处于平衡状态。这些催化体系对于高配位底物的不对称胺化反应以及α - 氰基酮的曼尼希型反应是有效的,其中氢键协同促进底物活化和立体分化。这里描述的大多数反应生成了手性四取代碳或季碳,即使是用现代合成方法这也是值得注意的成就。一些反应已被纳入治疗药物(或其候选分子)如达菲、AS - 3201(雷尼司他)、GRL - 06579A和利托君的不对称合成中,说明了双功能不对称催化的实用性。